BioCardia (BCDA) Retained Earnings (2010 - 2026)

BioCardia (BCDA) has reported Retained Earnings for 16 consecutive years, with $174.9 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Retained Earnings rose 206.07% year-over-year to $174.9 million in Q2 2026; TTM through Jun 2026 was $174.9 million, a 206.07% increase from a year earlier, with the FY2025 full-year figure at $169.2 million, up 5.14% from the prior year.
• Retained Earnings was $174.9 million for Q2 2026 at BioCardia, up from -$170.6 million in the prior quarter.
• Over five years, Retained Earnings peaked at $174.9 million in Q2 2026 and troughed at -$170.6 million in Q1 2026.
• A 5-year average of $32.5 million and a median of $141.4 million in 2022 frame the typical range for Retained Earnings.
• Across the five-year window, Retained Earnings plunged 205.96% in 2023 and soared 206.98% in 2024, its largest moves.
• Over 5 years, Retained Earnings stood at $145.5 million in 2022, then tumbled by 204.6% to -$152.2 million in 2023, then soared by 205.77% to $161.0 million in 2024, then grew by 5.14% to $169.2 million in 2025, then grew by 3.35% to $174.9 million in 2026.
• The last three Retained Earnings figures came in at $174.9 million (Q2 2026), -$170.6 million (Q1 2026), and $169.2 million (Q4 2025), per Business Quant data.